IL114130A0 - Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
IL114130A0
IL114130A0 IL11413095A IL11413095A IL114130A0 IL 114130 A0 IL114130 A0 IL 114130A0 IL 11413095 A IL11413095 A IL 11413095A IL 11413095 A IL11413095 A IL 11413095A IL 114130 A0 IL114130 A0 IL 114130A0
Authority
IL
Israel
Prior art keywords
treatment
composition
withdrawal symptoms
nicotine craving
smoking withdrawal
Prior art date
Application number
IL11413095A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL114130A0 publication Critical patent/IL114130A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11413095A 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms IL114130A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26466694A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
IL114130A0 true IL114130A0 (en) 1995-10-31

Family

ID=23007084

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11413095A IL114130A0 (en) 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2702795A (fr)
IL (1) IL114130A0 (fr)
MA (1) MA23586A1 (fr)
PE (1) PE39996A1 (fr)
WO (1) WO1996000069A1 (fr)
ZA (1) ZA955033B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2340397A (en) * 1996-03-21 1997-10-10 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
WO2001041732A1 (fr) * 1999-12-06 2001-06-14 Gore Stanley L Compositions et procedes d'administration intranasale d'agents actifs destines au cerveau
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
EP1625333A1 (fr) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Unite de chauffage autonome et unite de fourniture de medicament faisant appel a cette unite de chauffage
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4959380A (en) * 1988-12-19 1990-09-25 Wilson Jordan E Method of treating people to stop smoking and composition
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
PE39996A1 (es) 1996-10-03
AU2702795A (en) 1996-01-19
MA23586A1 (fr) 1995-12-31
WO1996000069A1 (fr) 1996-01-04
ZA955033B (en) 1996-02-15

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0713655A3 (fr) Succédané de cigarette et son procédé de fabrication
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
PL318153A1 (en) Smoking article and cigarette of low co content
EP0632969A3 (fr) Cordon filtrant et son procédé de fabrication ainsi qu'une filtre pour fumée de tabac et son procédé de fabrication.
EP0777473A4 (fr) Compositions et procedes visant a reduire l'usage du tabac
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0632968A3 (fr) Cordon filtrant et son procédé de fabrication ainsi qu'un filtre pour fumée de tabac et son procédé de fabrication.
IL126683A0 (en) Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
IL114130A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
GB9504611D0 (en) Filter for smoking article and smoking article incorporating it
EP0496148A3 (en) Improvements in the treatment of ashes
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
GB2222066B (en) Method of increasing the hardness of cigarette filter elements
GB2289612B (en) Tobacco smokers' mouthpieces
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
GB9304027D0 (en) Packet for blocks of cigarettes and the like
GB9423119D0 (en) Tobacco rod and/or filter for smoking article
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
AU2107097A (en) Smoking mixture for use in the treatment of drug dependency
EP0443749A3 (en) Cigarette or cigar
GB9325247D0 (en) Smokers'ashtray
PL324045A1 (en) Pharmaceutic composition assisting in treatment of tobacco smoking dependence